Inherited susceptibility to several cancers but absence of linkage between dysplastic nevus syndrome and CDKN2A in a melanoma family with a mutation in the CDKN2A (P16INK4A) gene

Human Genetics

Volumn 101, Issue 3, 1997, Pages 359-364

  Puig, Susana ^a   Ruiz, Anna ^b   Castel, Teresa ^a   Volpini, Victor ^b   Malvehy, Josep ^a   Cardellach, Francesc ^a   Lynch, Michael ^b   Mascaro, Jose M ^a   Estivill, Xavier ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER GENETICS; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME 9P; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASTIC NEVUS; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; LUNG CARCINOMA; MALE; MELANOMA; PANCREAS ADENOCARCINOMA; PEDIGREE ANALYSIS; PENETRANCE; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; DISEASE SUSCEPTIBILITY; DYSPLASTIC NEVUS SYNDROME; FEMALE; FRAMESHIFT MUTATION; GENES, P16; HUMANS; LOD SCORE; LUNG NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; SPAIN;

EID: 0031448010     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050642     Document Type: Article

References (54)

1. Bale SJ, Dracopoli SC, Tucker MA, Clark WH, Fraser MC, Stanger BZ, Green P, Donis-Keller H, Houssman DE, Green MH (1989) Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med 320:1367-1372
2. Bergman W, Watson P, Jong J de, Lynch HT, Fusaro RM (1990) Systemic cancer and the FAMMM syndrome. Br J Cancer 61: 932-936
3. Borg A, Johansson U, Hakansson S, Westerdahl J, Masback A, Olsson H, Ingvar C (1996) Novel germline p16 mutation in familial melanoma in southern Sweden. Cancer Res 56: 2497-2500
4. Caldas C, Hahn SA, Costa LT da, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenoearcinoma. Nat Genet 8: 27-32
5. Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, Hegi ME, Wiseman RW, Petty EM, Bale AE, Olopade OI, Diaz MO, Kwiatkowski DJ, Piepkorn MW, Zone JJ, Skolnick MH (1992) Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-22. Science 258: 1148-1152
6. Carrel L, Willard HF (1996) An assay for X inactivation based on differential methylation at the fragile X locus, FMR1. Am J Med Genet 64:27-30
7. Ciotti P, Strigini P, Bianchi-Scarra G (1996) Familial melanoma and pancreatic cancer. N Engl J Med 334:469-470
8. Clark WH, Reimer RR, Greene M, Ainsworth AM, Mastrangelo MJ (1978) Origin of familial malignant melanomas from heritable melanocytic lesions. Arch Dermatol 114:732-738
9. Fitzgerald MG, Harkin DP, Silva-Arrieta S, MacDonald DJ, Lucchina LC, Unsal H, O'Neill E, Koh J, Finkelstein DM, Isselbacher KJ, Sober AJ, Haber DA (1996) Prevalence of germline mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. Proc Natl Acad Sci USA 93:8541-8545
10. Goldstein AM, Dracopoli NC, Ho EC, Fraser MC, Kearns KS, Bale SJ, McBride OW, Clark WH Jr, Tucker MA (1993) Further evidence for a locus for cutaneous malignant-melanoma dysplastic nevus (cmm/dn) on chromosome 1p, and evidence for genetic heterogeneity. Am J Hum Genet 52:537-550
11. Goldstein AM, Dracopoli NC, Engelstein M, Frase MC, Clark WH, Tucker MA ( 1994) Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity. Am J Hum Genet 54:489-496
12. INK4 mutations. N Engl J Med 333:970-974
13. Goldstein AM, Goldin R, Dracopoli NC, Clark WH Jr, Tucker MA (1996) Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi. Am J Hum Genet 58:1050-1056
14. Greene MH, Fraumeni JF Jr (1979) The hereditary variant of malignant melanoma. Grune and Stratton, New York
15. Gruis NA, Velden PA van der, Sandkuijl LA, Prins DE, Weaver-Feldhaus J, Kamb A, Bergman W, Frants RR (1995) Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet 10:351-353
16. Hayashi N, Sugimota Y, Tsuchiya E, Ogawa M, Nakamura Y (1994) Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK4I (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas. Biochem Biophys Res Commun 202:1426-1430
17. INK4 in sporadic melanoma. J Invest Dermatol 107:318-321
18. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826
19. Holland EA, Beaton SC, Becker TM, Grulet OMC, Peters BA, Rizos H, Kefford RF, Mann GJ (1995) Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds. Oncogene 11: 2289-2294
20. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA, Dracopoli NC (1994) Germline p16 mutations in familial melanoma. Nat Genet 8:15-21
21. Kamb A, Shattuck-Eidens A, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, McClure M, Aitken JF, Anderson DE, Bergman W, Frants R, Goldgar DE, Green A, MacLennan R, Martin NG, Meyer U, Youl P, Zone JJ, Skolnick NH, Cannon-Albright LA (1994) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8:22-26
22. Komiya A, Suzuku H, Aida S, Yatani R, Shimazaki J (1995) Mutational analysis of the CDKN2 (CDK4I/MTS1) gene in tissues and cell lines of human prostate cancer. Jpn J Cancer Res 86:622-625
23. Kraehn GM, Schartl M, Peter RU (1995) Human malignant melanoma. A genetic disease? Cancer 75:1228-1237
24. Lathrop GM, Lalouel JM (1984) Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet 36:460-465
25. INK4A mutation and protein dysfunction in a family with inherited melanoma. Oncogene 11:405-412
26. Liu Q, Neuhausen S, McClure M, Frye C, Weaver-Feldhaus J, Gruis NA, Eddington K, Allalunis-Turner MJ, Skolnick MH, Fujimura FK, Kamb A (1995 b) CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene 10:1061-1067
27. Lynch HT, Fusaro RM (1991) Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome. Pancreas 6:127-131
28. Lynch HT, Frichot BC, Lynch JF (1978) Familial atypical multiple-mole melanoma syndrome. J Med Genet 15:352-356
29. Lynch HT, Fusaro RM, Kimberling WJ, Lynch JF, Danes BS (1983) Familial atypical multiple-mole melanoma (FAMMM) syndrome: segregation analysis. J Med Genet 20:342-344
30. MacGeoch C, Newton Bishop JA, Bataille V, Bishop DT, Frischauf AM, Meloni R, Cuzick J, Pinney E, Spurr NK (1994) Genetic heterogeneity in familial malignant melanoma. Hum Mol Genet 3:2195-2200
31. INK4A transcript. Cancer Res 55:2995-2997
32. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancer. Nat Med 1:686-692
33. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y (1994) Frequent somatic mutations of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54:3396-3397
34. Moulton T, Samara G, Chung WY, Yuan L, Desai R, Sisti M, Bruce J, Tycko B (1995) MTS 1/p16/CDKN2 lesions in primary glioblastoma multiforme. Am J Pathol 146:613-619
35. Muir C (1987) Cancer incidence in five continents, vol 5. International Agency for Research on Cancer, Lyon
36. Nancarrow DJ, Mann GJ, Holland EA, Walker GJ, Beaton SC, Walters MK, Luxford C, Palmer JM, Donald JA, Weber JL, Fountain JW, Kefford RF, Hay ward NK (1993) Confirmation of chromosome 9p linkage in familial melanoma. Am J Hum Genet 53:936-942
37. INK4 protein induction by 5-aza 2′ deoxycytidine. Oncogene 11:1211-1216
38. Puig S, Ruiz A, Lazaro C, Castel T, Lynch M, Palou J, Vilalta A, Weissenbach J, Mascaro JM, Estivill X (1995) Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene. Am J Hum Genet 57:395-402
39. Quelle DE, Cheng M, Ashmun RA, Sherr CJ (1997) Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF. Proc Natl Acad Sci USA 94:669-673
40. Raymond A, Brent R (1995) p16 proteins from melanoma-prone families are deficient in binding to CDK4. Oncogene 11:1173-1178
41. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G, Kamb A (1995) Complex structure and regulation of the P16 (MTS1) locus. Cancer Res 55:2988-2994
42. Takeuchi S, Bartram CR, Seriu T, Miller CW, Tobler A, Janssen JWG, Reiter A, Ludwig W-D, Zimmermann M, Schwaller J, Lee E, Miyoshi I, Koeffler HP (1995) Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2I/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood 86:755-760
43. ink4A) gene in primary B-cell lymphomas. Blood 86:2724-2731
44. Ueki K, Rubio MP, Ramesh V, Coffea KM, Rutter JL, Deimling A von, Buckler AJ, Gusella JF, Louis DN (1995) MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum Mol Genet 3:1841-1845
45. Vergara Ugarriza A, Lázaro Belanche MA, Guimbao Bescos J, Moreo Bergada P (1997) Incidencia de c·ncer en Zaragoza 1987-1990. Registre de Cáncer de Zaragoza
46. Walker GJ, Hussussian CJ, Flores JF, Glendening JM, Haluska FG, Dracopoli NC, Hayward NK, Fountain JW (1995) Mutations of the CDKN2/p161NK4 gene in Australian melanoma kindreds. Hum Mol Genet 4:1845-1852
47. Whelan AJ, Bartsch D, Goodfellow PJ (1995) A familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N Engl J Med 333:975-977
48. Williamson MP, Elder PA, Shaw ME, Devlin J, Knowles MA (1995) p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum Mol Genet 4:1569-1577
49. Xiao S, Li D, Corson JM, Vijg J, Fletcher JA (1995) Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Cancer Res 55:2968-2971
50. Yarbrough WG, Aprelikova O, Pei H, Olshan AF, Liu ET (1996) Familial tumor syndrome associated with germline nonfunctional p16INK4a allele. J Natl Cancer Inst 88:1489-1491
51. Yeudall WA, Crawford RY, Ensley JF, Robbins KC (1994) MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma. Carcinogenesis 15: 2683-2686
52. Yoshida S, Todoroki T, Ichikawa Y, Hanai S, Suzuki H, Hori M, Fukao K, Miwa M, Uchida K (1995) Mutations of the p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Cancer Res 55:2756-2760
53. Zhang SY, Klein-Szanto AJ, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T, Carson DA, Ridge JA, Goodrow TL (1994) Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinomas cell lines than in primary tumors of the head and neck. Cancer Res 54:5050-5053
54. Zhou X, Tarmin L, Yin J, Jiang HY, Suzuki H, Rhyu MG, Abraham JM, Meltzer SJ (1994) The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene 9:3737-3741